Human medicines European public assessment report (EPAR): Zytiga, abiraterone, Date of authorisation: 05/09/2011, Revision: 28, Status: Authorised

Submitted by Anonymous (not verified) on 18 October 2024 - 10:15

Human medicines European public assessment report (EPAR): Zytiga, abiraterone, Date of authorisation: 05/09/2011, Revision: 28, Status: Authorised

Human medicines European public assessment report (EPAR): Velcade, bortezomib, Date of authorisation: 26/04/2004, Revision: 46, Status: Authorised

Submitted by Anonymous (not verified) on 18 October 2024 - 10:10

Human medicines European public assessment report (EPAR): Velcade, bortezomib, Date of authorisation: 26/04/2004, Revision: 46, Status: Authorised

Training webinar on Product Management Service (PMS) Product User Interface (PUI), Online, from 16 October 2024, 10:00 (CEST) to 16 October 2024, 11:00 (CEST)

Submitted by Anonymous (not verified) on 18 October 2024 - 7:50

Training webinar on Product Management Service (PMS) Product User Interface (PUI), Online, from 16 October 2024, 10:00 (CEST) to 16 October 2024, 11:00 (CEST)

Human medicines European public assessment report (EPAR): Ciambra, pemetrexed, Date of authorisation: 02/12/2015, Revision: 7, Status: Withdrawn (authorisation)

Submitted by Anonymous (not verified) on 17 October 2024 - 16:40

Human medicines European public assessment report (EPAR): Ciambra, pemetrexed, Date of authorisation: 02/12/2015, Revision: 7, Status: Withdrawn (authorisation)

Babesia (B. microti, B, duncani, B. divergens, and B. venatorum) DNA and RNA - Notified body 2797 - 19/11/2021 - View in the context of the performance evaluation consultation procedure (PECP)

Submitted by Anonymous (not verified) on 17 October 2024 - 16:20

Babesia (B. microti, B, duncani, B. divergens, and B. venatorum) DNA and RNA - Notified body 2797 - 19/11/2021 - View in the context of the performance evaluation consultation procedure (PECP)

Shoulder prostheses - Notified body 0459 - 25/08/2022 - Expert decision and opinion in the context of the clinical evaluation consultation procedure (CECP)

Submitted by Anonymous (not verified) on 17 October 2024 - 15:20

Shoulder prostheses - Notified body 0459 - 25/08/2022 - Expert decision and opinion in the context of the clinical evaluation consultation procedure (CECP)

Human medicines European public assessment report (EPAR): Aldurazyme, laronidase, Date of authorisation: 09/06/2003, Revision: 27, Status: Authorised

Submitted by Anonymous (not verified) on 17 October 2024 - 14:46

Human medicines European public assessment report (EPAR): Aldurazyme, laronidase, Date of authorisation: 09/06/2003, Revision: 27, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness